Cholesterol & Recurrent Events (CARE) study

Introduction

Randomized controlled trial.

Enrollment:

• men & women age 65-75
• history of myocardial infarction
• total cholesterol < 240 mg/dL
• LDL cholesterol 115-174 mg/dL

Results:

• treatment with pravastatin 40 mg QD resulted in significantly fewer major coronary events & strokes during a 5 year follow-up

More general terms

• clinical trial